Stock Comparison
ABBV vs LLY
AbbVie Inc and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$1.08T
P/E (TTM)
123.6
42.9
Forward P/E
17.8
31.1
Price/Sales
7.1
14.9
Price/Book
50.5
32.2
EV/EBITDA
30.2
28.8
Dividend Yield
2.77%
0.55%
Profitability
Net Margin
5.79%
35.00%
Operating Margin
32.20%
49.40%
Return on Equity
62.30%
107.50%
Return on Assets
10.00%
20.70%
Growth (YoY)
Revenue Growth
12.40%
55.50%
Earnings Growth
-46.20%
169.90%
Price & Risk
Beta
0.3
0.5
52-Week High
$253.35
$1,215.76
52-Week Low
$176.02
$619.40
Analyst Target
$254.38
$1,222.62
Compare ABBV and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.